EKF Diagnostics Holdings Statistics

Total Valuation

EKF Diagnostics Holdings has a market cap or net worth of GBP 117.74 million. The enterprise value is 110.30 million.

Market Cap	117.74M
Enterprise Value	110.30M

Important Dates

The next estimated earnings date is Wednesday, December 18, 2024.

Earnings Date	Dec 18, 2024
Ex-Dividend Date	n/a

Share Statistics

EKF Diagnostics Holdings has 453.73 million shares outstanding. The number of shares has decreased by -0.21% in one year.

Current Share Class	n/a
Shares Outstanding	453.73M
Shares Change (YoY)	-0.21%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	76.25%
Float	380.37M

Valuation Ratios

The trailing PE ratio is 24.65 and the forward PE ratio is 22.39.

PE Ratio	24.65
Forward PE	22.39
PS Ratio	2.31
PB Ratio	1.71
P/TBV Ratio	n/a
P/FCF Ratio	17.01
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.66, with an EV/FCF ratio of 15.94.

EV / Earnings	23.10
EV / Sales	2.16
EV / EBITDA	9.66
EV / EBIT	16.19
EV / FCF	15.94

Financial Position

The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.02.

Current Ratio	4.60
Quick Ratio	3.08
Debt / Equity	0.02
Debt / EBITDA	0.11
Debt / FCF	0.18
Interest Coverage	40.56

Financial Efficiency

Return on equity (ROE) is 7.58% and return on invested capital (ROIC) is 6.21%.

Return on Equity (ROE)	7.58%
Return on Assets (ROA)	5.27%
Return on Capital (ROIC)	6.21%
Revenue Per Employee	164,890
Profits Per Employee	15,456
Employee Count	317
Asset Turnover	0.63
Inventory Turnover	3.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.57%
50-Day Moving Average	28.25
200-Day Moving Average	28.55
Relative Strength Index (RSI)	36.41
Average Volume (20 Days)	387,139

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EKF Diagnostics Holdings had revenue of GBP 50.95 million and earned 4.78 million in profits. Earnings per share was 0.01.

Revenue	50.95M
Gross Profit	24.48M
Operating Income	6.81M
Pretax Income	5.21M
Net Income	4.78M
EBITDA	10.77M
EBIT	6.81M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 9.82 million in cash and 1.25 million in debt, giving a net cash position of 8.57 million or 0.02 per share.

Cash & Cash Equivalents	9.82M
Total Debt	1.25M
Net Cash	8.57M
Net Cash Per Share	0.02
Equity (Book Value)	69.94M
Book Value Per Share	0.15
Working Capital	19.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.67 million and capital expenditures -4.75 million, giving a free cash flow of 6.92 million.

Operating Cash Flow	11.67M
Capital Expenditures	-4.75M
Free Cash Flow	6.92M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 48.05%, with operating and profit margins of 13.37% and 9.37%.

Gross Margin	48.05%
Operating Margin	13.37%
Pretax Margin	10.23%
Profit Margin	9.37%
EBITDA Margin	21.14%
EBIT Margin	13.37%
FCF Margin	13.59%

Dividends & Yields

This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 4.62%.

Dividend Per Share	0.01
Dividend Yield	4.62%
Dividend Growth (YoY)	-21.05%
Years of Dividend Growth	n/a
Payout Ratio	114.01%
Buyback Yield	0.21%
Shareholder Yield	4.84%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EKF Diagnostics Holdings has an Altman Z-Score of 10.35.

Altman Z-Score	10.35
Piotroski F-Score	n/a